{"pmid":32389524,"title":"How technology can help in oncologic patient management during COVID-19 outbreak.","text":["How technology can help in oncologic patient management during COVID-19 outbreak.","Eur J Surg Oncol","Mercantini, Paolo","Lucarini, Alessio","Mazzuca, Federica","Osti, Mattia Falchetto","Laghi, Andrea","32389524"],"journal":"Eur J Surg Oncol","authors":["Mercantini, Paolo","Lucarini, Alessio","Mazzuca, Federica","Osti, Mattia Falchetto","Laghi, Andrea"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389524","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ejso.2020.04.050","keywords":["covid-19","gastrointestinal cancer","multidisciplinary team","oncology"],"topics":["Prevention"],"weight":1,"_version_":1666528580032528384,"score":9.490897,"similar":[{"pmid":32291153,"pmcid":"PMC7142701","title":"COVID-19 pandemic & head and neck cancer patients management: The role of virtual multidisciplinary team meetings.","text":["COVID-19 pandemic & head and neck cancer patients management: The role of virtual multidisciplinary team meetings.","Oral Oncol","Salari, Abolfazl","Shirkhoda, Mohammad","32291153"],"journal":"Oral Oncol","authors":["Salari, Abolfazl","Shirkhoda, Mohammad"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32291153","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.oraloncology.2020.104693","keywords":["covid-19","head & neck cancer","multidisciplinary team"],"topics":["Prevention"],"weight":1,"_version_":1666138494484873216,"score":70.544464},{"pmid":32406749,"title":"Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care.","text":["Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care.","Future Oncol","Massari, Francesco","Mollica, Veronica","Salvagni, Stefania","Tognetto, Michele","Ardizzoni, Andrea","32406749"],"journal":"Future Oncol","authors":["Massari, Francesco","Mollica, Veronica","Salvagni, Stefania","Tognetto, Michele","Ardizzoni, Andrea"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32406749","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.2217/fon-2020-0364","keywords":["covid-19","clinical trials","coronavirus","oncology","patient benefit","treatment decisions"],"topics":["Prevention"],"weight":1,"_version_":1666802845316284417,"score":70.06791},{"pmid":32498556,"title":"Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes.","text":["Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes.","The COVID-19 pandemic continues to significantly impact the treatment of people living with aortic stenosis, and access to transcatheter aortic valve implantation. Transcatheter aortic valve implantation (TAVI) programmes require unique coordinated processes that are currently experiencing multiple disruptions and are guided by rapidly evolving protocols. We present a series of recommendations for TAVI programmes to adapt to the new demands, based on recent evidence and the international expertise of nurse leaders and collaborators in this field. Although recommended in most guidelines, the uptake of the role of the TAVI programme nurse is uneven across international regions. COVID-19 is further highlighting why a nurse-led central point of coordination and communication is a vital asset for patients and programmes. We propose an alternative streamlined evaluation pathway to minimize patients' pre-procedure exposure to the hospital environment while ensuring appropriate treatment decision and shared decision-making. The competing demands created by COVID-19 require vigilant wait list management, with risk stratification, telephone surveillance and optimized triage and prioritization. A minimalist approach with close scrutiny of all parts of the procedure has become an imperative to avoid any complications and ensure patients' accelerated recovery. Lastly, we outline a nurse-led protocol of rapid mobilization and reconditioning as an effective strategy to facilitate safe next-day discharge home. As the pandemic abates, TAVI programmes must facilitate access to care without compromising patient safety, enable hospitals to manage the competing demands created by COVID-19 and establish new processes to support patients living with valvular heart disease.","Eur J Cardiovasc Nurs","Lauck, Sandra","Forman, Jacqueline","Borregaard, Britt","Sathananthan, Janarthanan","Achtem, Leslie","McCalmont, Gemma","Muir, Douglas","Hawkey, Marian C","Smith, Amanda","Hojberg Kirk, Bettina","Wood, David A","Webb, John G","32498556"],"abstract":["The COVID-19 pandemic continues to significantly impact the treatment of people living with aortic stenosis, and access to transcatheter aortic valve implantation. Transcatheter aortic valve implantation (TAVI) programmes require unique coordinated processes that are currently experiencing multiple disruptions and are guided by rapidly evolving protocols. We present a series of recommendations for TAVI programmes to adapt to the new demands, based on recent evidence and the international expertise of nurse leaders and collaborators in this field. Although recommended in most guidelines, the uptake of the role of the TAVI programme nurse is uneven across international regions. COVID-19 is further highlighting why a nurse-led central point of coordination and communication is a vital asset for patients and programmes. We propose an alternative streamlined evaluation pathway to minimize patients' pre-procedure exposure to the hospital environment while ensuring appropriate treatment decision and shared decision-making. The competing demands created by COVID-19 require vigilant wait list management, with risk stratification, telephone surveillance and optimized triage and prioritization. A minimalist approach with close scrutiny of all parts of the procedure has become an imperative to avoid any complications and ensure patients' accelerated recovery. Lastly, we outline a nurse-led protocol of rapid mobilization and reconditioning as an effective strategy to facilitate safe next-day discharge home. As the pandemic abates, TAVI programmes must facilitate access to care without compromising patient safety, enable hospitals to manage the competing demands created by COVID-19 and establish new processes to support patients living with valvular heart disease."],"journal":"Eur J Cardiovasc Nurs","authors":["Lauck, Sandra","Forman, Jacqueline","Borregaard, Britt","Sathananthan, Janarthanan","Achtem, Leslie","McCalmont, Gemma","Muir, Douglas","Hawkey, Marian C","Smith, Amanda","Hojberg Kirk, Bettina","Wood, David A","Webb, John G"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32498556","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1474515120934057","keywords":["covid-19","transcatheter aortic valve implantation","clinical pathway","multidisciplinary team"],"topics":["Prevention"],"weight":1,"_version_":1668804508929490944,"score":62.598328},{"pmid":32439572,"title":"The impacts of the novel SARS-CoV-2 outbreak on surgical oncology - A letter to the editor on \"The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review\".","text":["The impacts of the novel SARS-CoV-2 outbreak on surgical oncology - A letter to the editor on \"The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review\".","Int J Surg","Shubber, Nour","Sheppard, Jack","Alradhawi, Mohammad","Ali, Yousif","32439572"],"journal":"Int J Surg","authors":["Shubber, Nour","Sheppard, Jack","Alradhawi, Mohammad","Ali, Yousif"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32439572","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ijsu.2020.05.032","keywords":["covid-19","cancer","coronavirus","oncology","sars-cov-2","surgery","united kingdom uk"],"topics":["Prevention"],"weight":1,"_version_":1667535119423897600,"score":58.046032},{"pmid":32484908,"title":"Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.","text":["Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.","The COVID-19 pandemic has far-reaching ramifications for patients undergoing cancer treatment. Oncologists and institutions have adjusted treatment practices and, in many cases, significantly curtailed clinical trial conduct. Whether these adjustments mitigate the risk of COVID-19 complications without jeopardizing treatment of the cancer is unknown. Given the expected duration of the pandemic, it is imperative that treatment of the patient's cancer remain the priority and that advances in drug development continue through appropriately designed clinical trials.","Clin Pharmacol Ther","Holstein, Sarah A","Vose, Julie M","32484908"],"abstract":["The COVID-19 pandemic has far-reaching ramifications for patients undergoing cancer treatment. Oncologists and institutions have adjusted treatment practices and, in many cases, significantly curtailed clinical trial conduct. Whether these adjustments mitigate the risk of COVID-19 complications without jeopardizing treatment of the cancer is unknown. Given the expected duration of the pandemic, it is imperative that treatment of the patient's cancer remain the priority and that advances in drug development continue through appropriately designed clinical trials."],"journal":"Clin Pharmacol Ther","authors":["Holstein, Sarah A","Vose, Julie M"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484908","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/cpt.1920","keywords":["covid-19","clinical trials","oncology","translational medicine"],"topics":["Prevention"],"weight":1,"_version_":1668704334432436224,"score":57.261566}]}